Biopsy Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Disease Type, By Anatomy, By Guidance Technique, By Region and Competition, 2020-2030F
The Global Biopsy Devices Market was valued at USD 6.17 billion in 2024 and is anticipated to reach USD 8.84 billion by 2030, registering a CAGR of 6.18% during the forecast period. This market is a vital segment of the healthcare industry, driven by the growing incidence of cancer and the need for precise diagnostic methods. Biopsy devices are essential in identifying diseases at early stages, particularly cancer, by collecting tissue samples for analysis. The demand is further fueled by technological innovations, an aging population, and the increasing preference for minimally invasive procedures like image-guided and liquid biopsies. Advancements in robotics and AI are also enhancing diagnostic accuracy and procedural efficiency.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 6.17 Billion
Market Size 2030
USD 8.84 Billion
CAGR 2025-2030
6.18%
Fastest Growing Segment
Liquid Biopsy
Largest Market
North America
Key Market Drivers
Rising Cancer Prevalence
The escalating global incidence of cancer significantly propels the demand for biopsy devices. As cancer becomes more widespread, the need for accurate diagnostic methods grows more urgent. Biopsy procedures are critical in confirming cancer diagnoses, determining types and stages, and guiding effective treatment plans. According to the Union for International Cancer Control (UICC), the number of new cancer cases is projected to exceed 35 million by 2050, marking a 77% increase from 2022. This alarming rise underscores the importance of biopsy tools in healthcare systems, as early and reliable diagnosis is central to improving patient outcomes and expanding access to appropriate therapies.
Key Market Challenges
High Cost of Biopsy Procedures
A significant challenge for the global biopsy devices market is the high cost associated with biopsy procedures. These costs include not only the price of specialized equipment but also expenses related to diagnostics, professional services, and post-procedure care. For patients, especially those with limited financial means or inadequate insurance coverage, out-of-pocket expenses can deter timely diagnosis. Even for healthcare providers, the acquisition and maintenance of advanced biopsy equipment, workforce training, and regulatory compliance impose substantial financial burdens. These economic constraints limit accessibility and slow adoption, particularly in developing regions, posing a barrier to market expansion.
Key Market Trends
Growth of Minimally Invasive Techniques
The increasing adoption of minimally invasive biopsy techniques is a transformative trend in the global biopsy devices market. Unlike traditional surgical biopsies, these methods-such as fine-needle aspiration, core needle biopsies, and image-guided procedures-offer less invasive alternatives with reduced discomfort and faster recovery. These patient-friendly approaches not only improve diagnostic efficiency but also increase the appeal of biopsy procedures, driving demand. Minimally invasive methods enable sampling from hard-to-reach areas and are associated with lower complication rates. Their growing acceptance among both patients and providers is accelerating market growth and reshaping diagnostic practices across healthcare systems.
Key Market Players
Argon Medical Devices, Inc.
B. Braun SE
Becton, Dickinson and Company
Boston Scientific Corporation
Cardinal Health, Inc.
Cook Medical Inc.
Conmed Corporation
FUJIFILM Holdings Corporation
GE HealthCare
Inrad, Inc
Report Scope:
In this report, the Global Biopsy Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Biopsy Devices Market, By Product Type:
Tissue Biopsy
Liquid Biopsy
Biopsy Devices Market, By Disease Type:
Cancer
Infections
Autoimmune Disorders
Non-Cancerous Indications
Others
Biopsy Devices Market, By Anatomy:
Breast
Lung
Bone
Liver
Uterus/Cervix/Ovary
Abdomen
Prostate
Cardiac
Skin
Others
Biopsy Devices Market, By Guidance Technique:
X-Ray-Guided Biopsy
Ultrasound-Guided Biopsy
MRI-Guided Biopsy
CT-Guided Biopsy
Biopsy Devices Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Biopsy Devices Market.
Available Customizations:
Global Biopsy Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Global Biopsy Devices Market Outlook
4.1. Market Size & Forecast
4.1.1. By Value
4.2. Market Share & Forecast
4.2.1. By Product Type (Tissue Biopsy, Liquid Biopsy)
4.2.2. By Disease Type (Cancer, Infections, Autoimmune Disorders, Non-Cancerous Indications, Others)